Thousands of runners who braved the scorching heat early Saturday, July 24 for the Bix 7 race got a glimpse of the heart of the Hilltop Campus Village (HCV) in Davenport.
Though they likely did not stop then for a stirring jolt of coffee or admire some of the area’s striking architecture, Scott Tunnicliff and Molly
Molly Otting Carlson will start as new HCV executive director on Aug. 2.
Otting Carlson certainly hope they’ll be back soon to take in all the area has to offer.
Tunnicliff – an avuncular, dedicated 66-year-old economic development leader – recently retired as the first HCV director in its 12-year history. Carlson, a 52-year-old Davenport native, left her job as a vice president at Visit Quad Cities to take the reins of the nonprofit (and only Main Street Iowa organization in Scott County) as of Aug. 2.
Local News: The Iowa Gallivant visits Cherokee County (6/28/21)
chronicletimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chronicletimes.com Daily Mail and Mail on Sunday newspapers.
Mercato ortofrutticolo, oggi incontro tra Comune e concessionari
palermomania.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from palermomania.it Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ROCHESTER, Minn., April 19, 2021 /PRNewswire/ Nanodropper, Inc., a medical device company offering a first-of-its-kind eyedrop bottle adaptor that reduces eyedrop size, recently completed a $1.4 million seed round.
Golden Seeds, a recognized leader in the movement to accelerate funding to women entrepreneurs, represents Nanodropper s first institutional investor after a multiple-year run of non-dilutive funding through inventor competitions, state and local grant support, and an initial funding round of investors that included optometrists, ophthalmologists, and other healthcare professionals who believe in Nanodropper s product and business model. Golden Seeds is delighted to be an investor in Nanodropper. We believe the company solves a crucial problem well known by clinicians, payors and most importantly patients. This product is expected to provide much needed precision for glaucoma patients while providing a more cost effective s